Agilent Technologies, Inc. (A): Price and Financial Metrics
Agilent Technologies, Inc. (A)
Today's Latest Price: $114.57 USD
Updated Dec 2 4:02pm
Add A to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 58 in Medical - Diagnostics/Research
See all "A" rated Strong Buy stocks
A Stock Summary
- With a market capitalization of $35,566,599,494, Agilent Technologies Inc has a greater market value than 93.8% of US stocks.
- A's current price/earnings ratio is 51.47, which is higher than 81.6% of US stocks with positive earnings.
- Price to trailing twelve month operating cash flow for A is currently 41.45, higher than 90% of US stocks with positive operating cash flow.
- Stocks with similar financial metrics, market capitalization, and price volatility to Agilent Technologies Inc are RMD, BAX, CMI, CSGP, and IDXX.
- A's SEC filings can be seen here. And to visit Agilent Technologies Inc's official web site, go to www.agilent.com.
A Stock Price Chart Interactive Chart >
A Price/Volume Stats
| Current price | $114.57 | 52-week high | $118.96 |
| Prev. close | $115.36 | 52-week low | $61.13 |
| Day low | $114.13 | Volume | 1,735,789 |
| Day high | $115.95 | Avg. volume | 1,873,311 |
| 50-day MA | $106.56 | Dividend yield | 0.62% |
| 200-day MA | $91.09 | Market Cap | 35.32B |
Agilent Technologies, Inc. (A) Company Bio
Agilent Technologies provides bio-analytical solutions and services to the life sciences, diagnostics and genomics, chemical analysis, communications, and electronics industries worldwide. The company was founded in 1999 and is based in Santa Clara, California.
A Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $114.57 | $39.98 | -66% |
We started the process of determining a valid price forecast for Agilent Technologies Inc with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Agilent Technologies Inc ranked in the 25th percentile in terms of potential gain offered. We should note, though, that all scenearios modelled for this stock suggest it is overvalued. As for the metrics that stood out in our discounted cash flow analysis of Agilent Technologies Inc, consider:
- The company has produced more trailing twelve month cash flow than 74.94% of its sector Healthcare.
- The business' balance sheet suggests that 6% of the company's capital is sourced from debt; this is greater than just 17.82% of the free cash flow producing stocks we're observing.
- A's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 2%; for context, that number is higher than 41.59% of tickers in our DCF set.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | -66% |
| 1% | -66% |
| 2% | -66% |
| 3% | -65% |
| 4% | -65% |
| 5% | -65% |
For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as A, try ILMN, SNN, ABC, LGND, and RMD.
Loading social stream, please wait...